tm
Seeing Is Believing
tm
Seeing Is Believing
VVOS is currently covered by 1 analysts
Vivos Therapeutics 's activity chart (see below) currently has 7 price targets and 11 ratings on display. The stock rating distribution of VVOS is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 116 days.
Highest price target for VVOS is $4, Lowest price target is $2.
Most recent stock forecast was given by SCOTT HENRY from ALLIANCE GLOBAL PARTNERS on 19-Nov-2024. First documented stock forecast 05-Jan-2021.
Currently out of the existing stock ratings of VVOS, 3 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Jan-2021
$6
$4.79 (395.87%)
1 years 9 months 25 days ago
(19-Nov-2024)
1/3 (33.33%)
$3.17 (112.01%)
232
Buy Since 17-Jan-2023
$62.5
3 years 6 months 5 days ago
(08-Mar-2023)
0/1 (0%)
$21.75 (53.37%)
What is VVOS (Vivos Therapeutics ) average time for price targets to be met?
Which analyst most recently updated their price target on VVOS (Vivos Therapeutics )?
Which analyst has the current lower performing score on VVOS (Vivos Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on VVOS (Vivos Therapeutics )?
Which analyst is the currently most bullish on VVOS (Vivos Therapeutics )?
Which analyst is the currently most reserved on VVOS (Vivos Therapeutics )?
